Trimodal imaging endoscopy may improve diagnostic accuracy of early gastric neoplasia: a feasibility study - 23/08/11
Reprint requests: Mitsuru Kaise, MD, Department of Endoscopy, Jikei University School of Medicine, 3-25-8 Nishishinbashi, Minato-ku, Tokyo 105-8461, Japan.Tokyo, Japan
Abstract |
Background |
A considerable number of superficial gastric neoplasias are overlooked with conventional white light imaging (WLI) endoscopy.
Objective |
The aim was to investigate the diagnostic potential of trimodal imaging endoscopy (TME), which combines WLI, autofluorescence imaging (AFI), and narrow-band imaging (NBI), for superficial gastric neoplasia.
Design |
Feasibility study.
Setting |
Single academic center.
Patients |
Sixty-two patients with or without gastric neoplasia.
Intervention |
Each patient serially assessed with WLI, AFI, and magnifying endoscopy with NBI (ME-NBI) by an endoscopist blinded for clinical information. ME-NBI over WLI and AFI was designated as TME. Histopathology of biopsy and ESD specimens was evaluated and used as the gold standard.
Main Outcome Measurements |
Sensitivity and specificity of endoscopic diagnosis of pathology-proven neoplasia by per-patient and per-lesion analyses.
Results |
The study included 47 pathology-proven neoplasias and 44 pathology-proven nonneoplasias that were detected as neoplasias with any of the modalities. By a per-lesion analysis, the sensitivity of TME (89.4%) was higher than that of WLI (76.6%) and AFI (68.1%). The specificity of TME (98.0%) was higher than that of WLI (84.3%) and AFI (23.5%). By a per-patient analysis, the sensitivity of TME (90.9%) was higher than that of WLI (75%) and AFI (68.2%). The specificity of TME (100%) was higher than that of WLI (72.2%) and AFI (44.4%).
Limitations |
Case-enriched population at a single center.
Conclusions |
Higher diagnostic accuracy of TME over conventional WLI indicates the feasibility of TME for the efficacious diagnosis of early gastric neoplasia.
Le texte complet de cet article est disponible en PDF.Abbreviations : AFE, AFI, BE, CI, ESD, FMS, ME-NBI, NBI, path-neoplasia, TME, WLI
Plan
| DISCLOSURE: All authors disclosed no financial relationships relevant to this publication. |
|
| If you would like to chat with an author of this article, you may contact him at masa-kato@jikei.ac.jp. |
Vol 70 - N° 5
P. 899-906 - novembre 2009 Retour au numéro
Article précédent
- EUS in pediatric patients
- Tan Attila, Douglas G. Adler, Kristen Hilden, Douglas O. Faigel
- EUS-FNA predicts 5-year survival in pancreatic endocrine tumors
- Fátima A.F. Figueiredo, Marc Giovannini, Genevieve Monges, Erwan Bories, Christian Pesenti, Fabrice Caillol, Jean Robert Delpero
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?